Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study.
Ye SL, Yang J, Bie P, Zhang S, Chen X, Liu F, Liu L, Zhou J, Dou K, Hao C, Shao G, Xia Q, Chen Y, Yang J, Deng X, Liu Y, Yuan Y, Fu Z, Nakajima K, Lv Z.
Ye SL, et al. Among authors: shao g.
BMC Cancer. 2018 Mar 2;18(1):247. doi: 10.1186/s12885-018-4144-9.
BMC Cancer. 2018.
PMID: 29499662
Free PMC article.